Powering AI-Driven Drug Discovery with President of Isomorphic Labs Max Jaderberg

The large part of the industry makes medicines is this very empirically driven process. Where things really fail is in the clinic, because we never could see the problems until we get to the point where we put these drugs in patients and we say, oh no, like there's toxicity that we didn't account for.

It goes beyond the title with direct discussion of know, like, really, including: Where things really fail is in the clinic, because we never could see the problems until we get to the point where we put these drugs in patients and we say, oh no, like there's to.

1. 01Demis, who pioneered a lot of models at DeepMind and other places, which I believe you sold the company to before, really helped with the inception and setup and now running the co
2. 02Personally, I was working on early days of generative models, language models, deep reinforcement learning, all of the big game playing challenge problems
3. 03and you know what are the problems we really need to be focusing this stuff on and i was you know i was thinking all of this of course demos was thinking all of this at the same ti